(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 million sales milestone payment from its ...

(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 million sales milestone payment from its ...

(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 million sales milestone payment from its ...

(IN BRIEF) Equinor ASA has initiated a share buy-back programme, set to run from 14 February 2025 to 15 January 2026, to meet obligations for its share-based incentive plans for employees and ...

Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 ...

Siemens Mobility has secured its first order for Vectron locomotives equipped with a battery power module that allows them to operate over short ...

Equinor has announced the start of the first tranche of its 2025 share buy-back programme, set to repurchase up to USD 396 million worth of share ...

The European Investment Fund (EIF) has approved a €100 million guarantee facility for Froda, increasing their lending capacity to support micro ...

Germany’s Institute for Federal Real Estate (BImA) has partnered with E.ON to install 7,000 electric vehicle charging points across federal pro ...

Siemens Smart Infrastructure has partnered with Aral pulse to implement Electrification X, a solution from Siemens Xcelerator, to enhance real-ti ...

Equinor ASA has initiated a share buy-back programme, set to run from 14 February 2025 to 15 January 2026, to meet obligations for its share-base ...

Vodafone and WWF have launched a new campaign featuring animal characters like Po the panda and Obi the ostrich to encourage people to donate unu ...